HOME >> BIOLOGY >> NEWS
Triple-vaccine strategy stimulates strong HIV-specific immune response in monkeys

PHILADELPHIA Researchers at The Wistar Institute and the University of Pennsylvania report success in monkeys of an innovative triple-vaccine strategy aimed at creating an effective anti-HIV vaccine regimen. In a test of the new approach, the scientists sought to maximize the immune response to a truncated HIV gene called Gag and succeeded in dramatically stimulating the production of CD8+ T cells responsive to Gag. Many scientists believe that CD8+ T cells will be an important key to creating an effective HIV vaccine.

"For a variety of reasons, it may not be possible to create a vaccine that generates antibodies able to neutralize HIV," says Hildegund C.J. Ertl, M.D., professor and immunology program leader at Wistar and senior author on the report published in the July issue of the Journal of Virology. "The next best thing may be to develop a vaccine that stimulates the production of anti-HIV CD8+ T cells, which have been shown in other studies to reduce viral load, although they do not prevent infection. The new vaccine regimen we tested induced unprecedented levels of CD8+ T cells in monkeys."

The experimental vaccines developed by Ertl and her colleagues take advantage of sophisticated bioengineering technologies and the special characteristics of a class of viruses called adenoviruses to create a series of three vaccines that, when given in sequence, build on each other to generate a stronger immune response than might otherwise be possible.

Many current vaccine development programs rely on human adenoviruses engineered to include elements from disease-causing agents, in part because adenoviruses are relatively easy to manipulate in the laboratory and readily enter a wide variety of cells, including important cells of the immune system, to stimulate a vigorous, long-lasting immune response.

A number of these vaccines based on common strains of human adenoviruses, including some against HIV, have returned positive results in ear
'"/>

Contact: Franklin Hoke
hoke@wistar.upenn.edu
215-898-3716
The Wistar Institute
8-Jul-2004


Page: 1 2 3

Related biology news :

1. A novel, safer strategy for regulating gene expression
2. New anti-inflammatory strategy for cancer therapy identified by UCSD researchers
3. European common frog found to use novel mating strategy
4. Promising hospital anti-infection strategy probably wont work, study shows
5. Parasitic cowbirds thrive with a less ruthless strategy than cuckoos
6. UK Government proposes long-term strategy for science
7. Scientists at Scripps Research describe new strategy for the synthesis of glycoproteins
8. International HapMap Consortium publishes scientific strategy
9. HPV testing could be future strategy for primary screening for cervical cancer
10. Scientists develop a novel strategy to help prevent transplant rejection
11. NIH announces strategy to accelerate medical research progress

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/17/2019)... ... 16, 2019 , ... LeadingBiotech , an exclusive event ... its NY/NJ CEO conference to be held on November 5, 2019 ... The event offers senior-level industry leaders a unique opportunity to collaborate, build partnerships ...
(Date:10/11/2019)... ... , ... Advanced Clinical, a clinical research services organization, is ... appointed Therapeutic Lead for Oncology. Dr. Tyan brings a wealth of practical, therapeutic, ... delivery credentials previously offered at Advanced Clinical. , Dr. Tyan has worked extensively ...
(Date:10/10/2019)... ... October 10, 2019 , ... Mindray, a ... attendees of the American Society of Anesthesiologists 2019 Annual Meeting to visit exhibit ... 19-21 in Orlando, Florida, and will provide more than 14,000 healthcare professionals from ...
Breaking Biology News(10 mins):
(Date:10/3/2019)... ... October 02, 2019 , ... Today marked the ... is enabling clinical program outsourcing success by cultivating radical improvements in leadership, staff, ... veteran executive Brenda Reese, phaseUP™ brings clients deep, broad and unique expertise in ...
(Date:10/3/2019)... (PRWEB) , ... October 02, 2019 , ... eKare’s inSight® ... NHS Digital Health Accelerator run by the East Midlands Academic Health Science Network (EMAHSN), ... adoption of technology in NHS by providing support to develop and deploy solutions to ...
(Date:10/3/2019)... ... 2019 , ... Yesterday, at the 2019 meeting of Outsourcing in Clinical Trials ... Sherley, M.D., Ph.D., discussed important design factors that currently limit the success of early ... suppliers of clinical trials, in his talk Dr. Sherley focused on the ...
(Date:9/24/2019)... WEST LAFAYETTE, Ind. (PRWEB) , ... ... ... Pharma LLC will be presenting their latest research in the area of ... Monday, November 4th, Dr. Pamela Smith, COO of Improved Pharma, will present ...
Breaking Biology Technology:
Cached News: